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During the past several years the dissociation of filterable viruses 
from combination with specific immune sera has aroused increasing 
attention. 
The fundamental observations of Arrhenius and Madsen (1) on the separation of 
diphtheria  toxin from its specific  antitoxin followed the classical experiments of 
yon Behring  (2),  pointing out the possibility of employing such toxin-antitoxin 
mixtures to stimulate the production of an artificial,  active immunity.  Success 
in that field induced Besredka (3)  to apply the principle to the use of sensitized 
bacterial vaccines.  Later, Andrewes (4) investigated the possibility of separating 
active virus from an innocuous ~n~ture of such a  virus and specific antiserum. 
Both filtration through a Berkefeld candle and dilution were found to be effective 
in bringing about a separation.  Long and Olitsky (5) brought forward additional 
evidence on this subject,  confirming and extending  the work of Andrewes,  and 
suggesting a  physico-chemical explanation  of the underlying mechanism. 
Following the observations concerning the dissociability of virus- 
immune serum mixtures, experiments were carried out in  this  lab- 
oratory in order to determine whether a virus can be separated from 
combination with the immune serum in ~ivo in such a manner as to 
induce a state of active immunity. 
These experiments were suggested by an observation of Andrewes on a group of 
rabbits  treated  by the injection of vaccine virus in one ear vein coincidentally 
with an injection of immune serum by way of the other ear vein.  When subse- 
quently tested by an intradermal inoculation of active vaccine virus, part of the 
treated  rabbits  were found to be immune.  Substitution  of actual mixtures  of 
virus and serum for the coincidental injection of the two factors was found by us 
to be equally efficacious,  and the immunity so produced was of a degree enabling 
animals, otherwise susceptible, to resist inoculation with active virus alone. 
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The experiment (6) consisted of the use of vaccine virus mixed with immune 
serum in such proportions that the material was without effect when inoculated 
intradermaUy in normal animals.  On the other hand, in the presence of an excess 
of immune bodies the mixtures were ineffective, presumably because sufficient 
dissociation of the infectious agent did not occur. 
The success achieved in the instances recorded led to the application 
here described of the same procedure to  the virus of poliomyelitis. 
Highly potent virus strains were available,  as were adequate stocks 
of human convalescent serum of proper inactivating power.  More- 
over, through the courtesy of Dr. W. H. Park, the globulin fraction 
of the serum of a  horse repeatedly injected with poliomyelitis virus 
was also studied.  The latter material had proved effective in activat- 
ing poliomyelitis virus in  vitro,  both  in  the laboratory of the New 
York City Department of Health (7) and in our hands (8). 
The various neutralizing sera were mixed with physiological saline 
suspensions of glycerolated poliomyelitic monkey spinal cord, shaken 
for 30 minutes at room temperature in a mechanical agitating device, 
allowed to stand for a similar period at the same temperature, and 
injected.  The  proportions  of  virus  and  immune  serum  employed 
were  shown  by  experiment  to  be  non-infectious  when  inoculated 
intracerebrally  into  normal  monkeys.  The  intradermal  and  sub- 
cutaneous  routes  were  chosen  for  the  injection  of  the  neutralized 
mixtures.  As shown by the individual protocols, the method of testing 
for the presence of immune bodies in the treated animals was varied 
somewhat,  in  order  to  study  the  problem  from  several  different 
aspects. 
A separate experiment was carried out to determine the efficacy of 
the poliomyelitis virus-antiserum mixtures, intranasally instilled,  to 
induce active  immunity.  When  vaccine virus  and  immune serum 
were instiUed into the nares of rabbits,  R.hoads (6)  secured a  certain 
degree of protection against inoculations of active virus alone.  Mon- 
keys, however, receiving similarly inactivated poliomyelitis virus  in 
considerable amounts by the same route over a  period of 2  weeks, 
failed to show distinct and unmistakable evidence of protection against 
a subsequent inoculation of potent virus. 
On the other hand, the intradermal and subcutaneous injections in 
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and  specific  antiserum  induced  a  varying  degree  of  protection,  as 
brought out in the protocols to follow.  The animals treated with the 
inactive  or neutral mixtures were submitted  to intracisternal,  intra- 
nasal,  and  intracerebral  inoculations  of  highly  potent  virus.  The 
results in  general were similar; one-half of the tested animals resisted 
an amount of potent virus sufficient to induce typical poliomyelitis in 
untreated  controls. 
As further indication that certain monkeys receiving the neutralized 
mixtures may attain a state of immunity to poliomyelitis, the results of 
tests of the specific neutralizing power of the serum of these animals 
may be  cited.  Of eight animals surviving the direct  inoculation  of 
virus,  the  sera  of  six  were  studied  for  their  neutralizing  capacity. 
Five  sera  neutralized or inactivated  an amount of  virus capable of 
producing typical  symptoms of poliomyelitis in the control  animals. 
Any possibility that the outcome could be due to a passive immunity 
conferred by the antiserum used in the treatment was ruled  out by 
previous  experimentation.  Pooled  human  immune  serum  given 
intravenously in amounts of 15 cc. failed to protect monkeys for more 
than a few days against intracerebral or intranasal virus inoculation. 
PROTOCOLS 
Experiment I.--Macacus rhesus monkeys of approximately the same size were 
given multiple intradermal inoculations on 20 different occasions.  The material 
injected was a  5 per cent physiological saline suspension of glycerolated "pooled 
mixed virus," mixed with an equal amount of pooled human convalescent serum. 
Previous experiments had shown that the proportions of serum and virus employed 
were ample to insure neutralization.  Each set of injections totalled 4 cc., and the 
treatments were repeated at 3 day intervals.  The animals were bled 30  days 
after the last injection, and the serum was separated and reserved for later study. 
•  The  entire group,  with an  untreated  control monkey,  was  subjected to  intra- 
cisternal inoculation of 2  ~.L.D.  of a  fresh BerkefeM filtrate of the same virus 
strain.  The control and 2 of the treated animals developed typical poliomyelitis, 
whereas the 2 remaining monkeys evinced no symptoms of disease.  The 4 sera 
were mixedwith fresh virus filtrate in the proportions of 0.99 cc. of serum to 0.01 
cc. of filtrate; kept in the incubator for 2 hours, allowed to stand over night in the 
icebox, and inoculated intracerebrally into normal monkeys.  The serum of the 2 
animals which ha  d resisted direct inoculation was found to be neutralizing, whereas 
that  of the 2  which  had  failed to  survive direct infection was  lacking in  this 
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The  result of this  experiment, then,  can be  stated as follows.  Two  of the 
animals wMch had received repeated intradermal inoculations of the neutralized 
mixtures resisted direct test and  their serum neutralized the virus,  whereas  2 
similarly treated  monkeys  succumbed  to  inoculation  and  proved  to  have  no 
appreciable neutralizing bodies in their serum. 
Experiment  //.--Four  Macacus  rhesus  monkeys  were  given  2  sets  of  sub- 
cutaneous  injections of  equal  parts  of pooled human  convalescent serum  and 
glycerolated "pooled mixed"  poliomyelitis virus.  Each  set  of  injections,  dis- 
tributed in multiple small blebs, involved a total of 30 cc. of the mixture, shaken 
and allowed to stand exactly as in Experiment I.  The treatment was repeated 
after a 5 day interval, and then 28 days were allowed to elapse before blood was 
collected and  the  serum  separated.  This  group was  tested  for  immunity  by 
repeated  intranasal  instillations of  glycerolated virus  suspension  of  the  same 
strain as that used in immunization.  Previous experimentation had shown that 
the instillation of 1 cc. of a 5 per cent virus supension into each nostril, repeated 
daily for  3  days,  was  practically uniformly  successful in  causing  infection  in 
normal animals.  This procedure was adopted as the test for immunity, since it was 
considered more comparable to the method of infection obtaining in man.  To 
make the results more reliable, 2 normal animals were used as controls.  11 days 
after the conclusion of the series of nasal instillations, 2  treated animals and  1 
control had developed typical poliomyelitis.  The remaining control and  the 2 
surviving treated monkeys were then subjected to a  repetition of the infecting 
procedure.  The  control  showed  characteristic  symptoms  15  days  after  the 
conclusion of the first series of instillations, or on the day following the end of the 
second series.  Bearing in mind the fact that an incubation period of 3  days or 
less is rare in experimental poliomyelitis, it is not unreasonable to suppose that 
the disease in the normal monkey resulted from the first rather  than from the 
second set of nasal instillations. 
Only the two sera of the treated monkeys which survived the foregoing proce- 
dures were tested for the presence of neutralizing antibodies.  The technique was 
the same as described in Experiment I; 0.01 cc. of virus was mixed with 0.99 cc. of 
serum, incubated for 2 hours at 37°C., and kept over night in the icebox.  The 
serum of one treated monkey neutralized, while that of the second treated monkey 
and the control failed to do so.  It is worthy of note that the animal receiving the 
serum of the treated monkey showed a  prolongation of  the  incubation  period, 
15 days, as compared with 8 days in the control. 
In brief, then, of 4 monkeys subjected to the subcutaneous injection of 60 ec. 
of a  mixture of equal parts of virus and immune serum, 2 survived the routine 
nasal  instillation of  virus,  although  2  controls  succumbed.  These  surviving 
animals also withstood a second course of nasal instillations  of active virus, without 
evincing any symptoms of the disease.  Of the sera of these 2 resistant animals, 
one neutralized virus, whereas the second failed to do so. 
Experiment  //I.--Four  Macacus rl~sus  monkeys were  treated  by  2  sets  of 
intradermal injections of 30 co. of a mixture of glycerolated "pooled mixed virus" c.  P. ~OADS  119 
suspension  and  pooled h-man  convalescent  serum,  equal  parts  of each  being 
employed.  This series was carried out in parallel with Experiment II, the same 
material  being used in both sets of animals.  The injections were given intra- 
dermally in this case instead of subcutaneously, as in the previous experiment. 
An interval of 5 days was allowed to elapse between the treatments and a  rest 
period of 28 days between the conclusion of the treatments and the withdrawal of 
blood for tests of the neutralizing value.  The animals received similar repeated 
nasal instillations of highly potent virus as in the group treated by subcutaneous 
injection, and the same controls were employed.  Of the 4 monkeys, 2 survived 2 
separate sets of intranasal instillations.  The sera of these 2 resistant animals were 
also tested for the power to neutralize poliomyelitis virus.  The same technique as 
previously  described  was  employed  and  both  sera  inactivated.  The  control, 
inoculated with  a  similar  amount  of untreated  virus,  developed  characteristic 
poliomyelitis. 
Here once more, one-half of the treated animals proved resistant to the repeated 
intranasal instillation of virus, and the sera of the protected animals were shown 
to be effective in neutralizing virus in vitro. 
Experiment  IV.--Four  Moxacus  rhesus  monkeys  received  repeated  sets  of 
intradermal  injections  of  glycerolated  "pooled  mixed  virus,"  inactivated  by 
admixture with 1/10th its volume of globulin fractionated horse antipoliomy¢litic 
serum.  Experimentation  had  demonstrated  that  such  a  preparation  would 
render inactive a S per cent physiological saline suspension of glycerolated nervous 
tissue of the "pooled mixed virus" strain, when mixed in the proportion of 1 part 
of globulin to 10 parts of virus.  Each  treatment  consisted of the  injection of 
15 co. of the mixture, distributed in multiple intradermal  blebs.  The injections 
were repeated S times at 3 day intervals.  A rest period of 1 month was anowed to 
intervene between the conclusion of the treatments and the  tests for ~mmunity. 
The first test comprised 3 sets of nasal instillations of active virus given at  dally 
intervals.  Two  treated  animals  showed no  evidence  of disease  following this 
procedure, one showed slight though definite  symptoms, with excitement, ruled 
fur,  and mild paralysis,  while  the fourth as well  as the  control developed  the 
clinical manifestations of poliomyelitis.  After 28 days the 3 surviving animals, 
together with a new control, were given intracerebral inoculations of 0.01 cc. of a 
fresh  Berkefeld  filtrate  of poliomyelitic nervous  tissue.  Although  the  control 
became prostrate on the seventh day after injection,  the 3 treated monkeys re- 
mained wen.  In the case of the animal which had shown mild symptoms after 
the first  test,  a  failure  to respond to the second was ascribed  to the preceding 
infection.  That the remaiuing 2 monkeys developed no symptoms indicated an 
immunity resulting from the treatments. 
Experiment. V.--Macacus  rhesus monkeys  were give daily intranasal instilla- 
tions of 5 per cent physiological saline suspensions of pollomyelitic nervous tissue 
mixed with an equal volume of pooled human convalescent serum.  The amount 
given at each treatment was 2 cc., 1 cc. being instilled in each nostril daily for 2 
weeks, making a total volume of 30 cc. of mixture.  A rest period of 30 days was 120  POLIOMYELITIS VIRUS  AND  ~MUNE  SERUh;[ 
allowed to elapse after the conclusion of the treatments.  The animals were then 
bled, the serum being stored for use in subsequent experiments.  Following  this 
procedure, the entire group, with an equivalent number of untreated controls, was 
subjected to repeated  intranasal  instillations of highly potent virus alone.  The 
control animals all developed typical experimental poliomyelitis on the seventh 
day following the termination  of the instillations.  Three  of the four treated 
monkeys became paralyzed on the fourteenth day; the fourth showed no symptoms 
at any time. 
It is evident from this experiment that  the intranasal instillation of 
neutralized  virus failed to give rise to demonstrable immunity  under 
the  experimental  conditions  observed.  An  adequate  explanation 
of the superiority of the intradermal and subcutaneous routes over the 
intranasal  can  only  be  a  matter  of  conjecture  at  this  time.  The 
fact that neutralizing substances for poliomyelitis virus are present in 
the nasal mucosae of normal adults may conceivably have a bearing on 
the matter. 
DISCUSSION 
The results  of the experiments described  in the foregoing  protocols 
indicate  that a varying degree of immunity to poliomyelitis  can be 
induced in  monkeys by the intradermal  and subcutaneous injection  of 
poliomyelitis  virus  neutralized  by mixture with human convalescent 
serum.  That the protection conferred by such  treatments is not 
constant,  or perhaps of  high degree,  is  evident  from the fact  that  only 
one-half of the treated animals survived the direct  inoculation  of 
virus.  Furthermore,  the serum of one of six survivors failed to 
neutralize a  small quantity  of poliomyelitis virus, although  the 
remaining five  effected  complete inactivation. On the other hand, 
six of eight animals which remained  well were retested by direct virus 
inoculation and proved  resistant. 
It is interesting  to compare  these experiments  with the refractory 
state  resulting  from  the  subcutaneous  inoculation  of  active  virus 
studied by Stewart and Rhoads (9), in which  it was shown that four 
of  eight  treated  animals  were  unable  to  resist  direct  intracerebral 
inoculation of rather weak virus strains. 
Aycock has  reported that  one animal in a  series of twelve treated 
by  intradermal  injections  of  active  virus  developed  poliomyelitis, c.  P.  I~XOADS  121 
an experience observed also in this laboratory.  It should be noted 
that  in the experiment reported in this  communication, no animal 
showed symptoms of disease during treatment, a  fact which is not 
surprising when the minimal infectivity of the inoculated material is 
considered.  The foregoing experiments suggest that the production 
of immune bodies in certain animals may follow  the injection of a 
neutralized  virus  ineffective in  producing  disease  symptoms  when 
inoculated intracerebrally in normal monkeys. 
SUMMARY AND  CONCLUSIONS 
1.  Experiments  are  reported  on  the  use  of  poliomyelitis  virus 
neutralized by specific  antiserum as  an agent to induce active  im- 
munity against the experimental disease in monkeys. 
2.  The  results indicate that protection  can be  conferred  upon  a 
certain number of the treated animals. 
3.  The neutralized material gave rise in no instance to symptoms of 
disease in the treated monkeys. 
4.  Active poliomyelitis virus,  suitably  neutralized  by  admixture 
with convalescent serum, was without pathogenic effect  when given 
by repeated nasal instillations. 
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